Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)

Clinical trial NCT02953704 · COMPLETED

Trial details

NCT number: NCT02953704
Sponsor: Incyte Corporation
Status: COMPLETED
Study type: OBSERVATIONAL

MPN (Myeloproliferative Neoplasms)

Start date: 2016-12-31
Primary completion: 2022-03-29
Enrollment: 1469

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.